These findings may account for why FMNL2 expressed differently in various breast cancer cell types; at least, compared to ER-positive MCF7 and T47D cells, FMNL2 expression was relatively high in ER-negative MDA-MB-231, BT549, and SUM159 cells. Here, FMNL2 is linked to breast carcinoma.